Bispecific CAR T-cell therapy: combining anti-CD19 and CD22 CAR T-cells Published 2018-01-05 Download video MP4 360p Recommendations 06:13 Lymphoma: Overview of Chimeric Antigen Receptor (CAR) T cells 04:51 BiTE®: Bispecific T Cell Engager 44:24 Basics of EP Testing and Ablation by Adam Zivin, M.D. 01:53 An update on the progress made in CAR T-cell therapy in India 01:36 Bispecific T-Cell Engagers (BiTEs) as Treatment of B-Cell Lymphoma 35:19 DocTalk Podcast: Understanding Lung Nodules 07:58 Dr. Mikhael on Challenges, Advances in Multiple Myeloma Treatment 02:07 Targeting BAFF-R with CAR-Ts to treat MCL 02:36 CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell ALL 19:51 Cancer Survivor Story: Non-Hodgkin Lymphoma | The Patient Story 06:23 The benefits of bispecific antibodies over CAR-T cell therapy in lymphoma 43:03 Cancer Survivor Story: Acute Myeloid Leukemia | McKenzie's Story | The Patient Story 01:07 Optimizing CAR-T therapy: regulating CAR T-cells in vivo 01:32 CAR T Cell Therapy Explained (Animation) | City of Hope 04:34 What Is the Future for CAR-T in Multiple Myeloma? 02:21 CAR T-Cell Therapy: How Does It Work? 01:19 Cytokine storms: CAR T-cell hyperinflammatory response distinct from cytokine release syndrome? 45:50 Treating Persistent/Chronic ITP Current Care, Future Potential Similar videos 03:52 Anti-CD22 CAR T-cells shift ALL into complete remission 11:22 CIPO2015: Dual Targeting of CD19 & CD22 on B-ALL Using a Single Bispecific Chimeric Antigen Receptor 03:34 Humanized versus murinized CD19/CD22 CAR-T cell therapy for R/R B-cell lymphoma 06:11 Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with relapsed/refracto... 04:47 CD19 CAR T-cells for adults 02:01 Anti CD22 CAR T cell therapy for relapsed paediatric ALL 57:03 CD19 CAR T Cell Therapy for Pediatric ALL: The Seattle Children’s Experience 1:01:59 Update on CAR T-Cell Therapy | LRF Webinars 01:58 CAR T-cell therapy and ALL: the current landscape 03:50 A new anti-CD22 CAR T immunotherapy for paediatric leukaemia 27:02 CAR T at UCLA: Driving the Progress of Engineered Cell Therapy | Sarah Larson, MD | UCLAMDChat 04:24 Key questions in the field of CD19 CAR T-cell therapy 02:00 Bispecific anti-CD20, anti-CD19 CAR-Ts for R/R NHL 02:12 Progression of CAR-T trials in China 03:28 Management of relapse after CAR-T More results